Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial

View ORCID ProfileEckhard F. Kleinau, Tilinao Lamba, Wanda Jaskiewicz, Katy Gorentz, Ines Hungerbuehler, Donya Rahimi, Demoubly Kokota, Limbika Maliwichi, Edister S. Jamu, Alex Zumazuma, Mariana Negrão, Raphael Mota, Yasmine Khouri, Michael Kapps
doi: https://doi.org/10.1101/2023.01.24.23284959
Eckhard F. Kleinau
1Global-Latin America and Caribbean (LAC)-West Africa Region, University Research Co. (URC), Chevy Chase, Maryland, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eckhard F. Kleinau
  • For correspondence: ekleinau@urc-chs.com
Tilinao Lamba
2Dept. of Psychology, University of Malawi – Chancellor College, Zomba, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanda Jaskiewicz
3Global Health Division, Chemonics International, Washington, District of Columbia, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katy Gorentz
3Global Health Division, Chemonics International, Washington, District of Columbia, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ines Hungerbuehler
4Clinical Division, Vitalk, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donya Rahimi
3Global Health Division, Chemonics International, Washington, District of Columbia, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Demoubly Kokota
2Dept. of Psychology, University of Malawi – Chancellor College, Zomba, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Limbika Maliwichi
2Dept. of Psychology, University of Malawi – Chancellor College, Zomba, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edister S. Jamu
2Dept. of Psychology, University of Malawi – Chancellor College, Zomba, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Zumazuma
5Department of Mental Health, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Negrão
4Clinical Division, Vitalk, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raphael Mota
4Clinical Division, Vitalk, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasmine Khouri
4Clinical Division, Vitalk, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kapps
4Clinical Division, Vitalk, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We conducted a randomized, controlled trial (RCT) to investigate our hypothesis that the interactive chatbot, Vitalk, is more effective in improving mental wellbeing and resilience outcomes of health workers in Malawi than the passive use of Internet resources.

For our 2-arm, 8-week, parallel RCT (ISRCTN Registry: trial ID ISRCTN16378480), we recruited participants from 8 professional cadres from public and private healthcare facilities. The treatment arm used Vitalk; the control arm received links to Internet resources. The research team was blinded to the assignment. Of 1,584 participants randomly assigned to the treatment and control arms, 215 participants in the treatment and 296 in the control group completed baseline and endline anxiety assessments. Six assessments provided outcome measures for: anxiety (GAD-7); depression (PHQ-9); burnout (OLBI); loneliness (ULCA); resilience (RS-14); and resilience-building activities. We analyzed effectiveness using mixed-effects linear models, effect size estimates, and reliable change in risk levels.

Results support our hypothesis. Difference-in-differences estimators showed that Vitalk reduced: depression (−0.68 [95% CI -1.15 to -0.21]); anxiety (−0.44 [95% CI -0.88 to 0.01]); and burnout (−0.58 [95% CI -1.32 to 0.15]). Changes in resilience (1.47 [95% CI 0.05 to 2.88]) and resilience-building activities (1.22 [95% CI 0.56 to 1.87]) were significantly greater in the treatment group. Our RCT produced a medium effect size for the treatment and a small effect size for the control group.

This is the first RCT of a mental health app for healthcare workers during the COVID-19 pandemic in Southern Africa combining multiple mental wellbeing outcomes, and measuring resilience and resilience-building activities. A significant number of participants could have benefited from mental health support (1 in 8 reported anxiety and depression; 3 in 4 suffered burnout; and 1 in 4 had low resilience). Such help is not readily available in Malawi. Vitalk has the potential to fill this gap.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN16378480

Clinical Protocols

https://www.isrctn.com/editorial/retrieveFile/1326fa36-af4d-4eb3-ad16-27f20f652ce1/41650

Funding Statement

Financial support for this RCT was provided by the United States Agency for International Development under the Cooperative Agreement No. AID-OAA-A-15-00046. The funders had no involvement in the analysis or in the decision to submit the paper for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of University of Malawi Research Ethics Committee (UNIMAREC) gave ethical approval for this work. Ethics committee/IRB of University Research Co. (URC) gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This study was registered with the ISRCTN clinical trial registry; trial registration number: ISRCTN16378480.

  • - Shortened the abstract to 300 words - Changed CONSORT diagram from Figure 3 to Figure 1 - Added specific dates and language related to ethics approval and trial registration - Specified the dates for participant recruitment

Data Availability

All data produced will be available online after acceptance of publication at https://data.usaid.gov/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted February 02, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial
Eckhard F. Kleinau, Tilinao Lamba, Wanda Jaskiewicz, Katy Gorentz, Ines Hungerbuehler, Donya Rahimi, Demoubly Kokota, Limbika Maliwichi, Edister S. Jamu, Alex Zumazuma, Mariana Negrão, Raphael Mota, Yasmine Khouri, Michael Kapps
medRxiv 2023.01.24.23284959; doi: https://doi.org/10.1101/2023.01.24.23284959
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial
Eckhard F. Kleinau, Tilinao Lamba, Wanda Jaskiewicz, Katy Gorentz, Ines Hungerbuehler, Donya Rahimi, Demoubly Kokota, Limbika Maliwichi, Edister S. Jamu, Alex Zumazuma, Mariana Negrão, Raphael Mota, Yasmine Khouri, Michael Kapps
medRxiv 2023.01.24.23284959; doi: https://doi.org/10.1101/2023.01.24.23284959

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Systems and Quality Improvement
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1752)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (658)
  • Epidemiology (10794)
  • Forensic Medicine (8)
  • Gastroenterology (586)
  • Genetic and Genomic Medicine (2943)
  • Geriatric Medicine (287)
  • Health Economics (532)
  • Health Informatics (1923)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (291)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12511)
  • Intensive Care and Critical Care Medicine (688)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2793)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1462)
  • Ophthalmology (443)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (365)
  • Primary Care Research (336)
  • Psychiatry and Clinical Psychology (2638)
  • Public and Global Health (5357)
  • Radiology and Imaging (1010)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)